AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)

AFSCME Urges Shareholders to Vote against Executive Compensation at Pfizer (PFE) and Johnson & Johnson (JNJ)

AFSCME is recommending that shareholders of both Pfizer and Johnson & Johnson vote against the executive compensation proposals at the annual meetings of both companies, which take place on April 28, 2011. 

AFSCME has led the charge to get shareholders of U.S. companies the right to vote on executive pay.  Thanks to the Wall Street Reform Act, shareholders now have a voice. "Now shareowners can use Say on Pay at all companies to register their disapproval of CEO pay," said President Gerald W. McEntee, whose 1.6 million members participate in public pension funds with combined assets worth more than $1 trillion. "It's up to investors to use this tool judiciously and send a clear message to boards of directors:  pay needs to be tied to performance."

Johnson & Johnson paid Chairman and CEO William Weldon nearly $29 million in spite of eleven recalls of JNJ drugs at a cost of $900 million.  The company lost $7 billion in market value last year.  JNJ also benchmarks its executive pay above the pay of its peers.

Pfizer's retired CEO Jeffrey Kindler received nearly $25 million, a 60 percent increase over his 2009 compensation. During Kindler's tenure, he received over $72 million in compensation during which time the stock price dropped by more than a third and Pfizer lost approximately $68 billion in market value.

"Pfizer's CEO pay is indefensible," added McEntee. "CEOs should not get massive rewards after shareholder value is destroyed on their watch. This lavish reward for failure is simply madness."

JNJ Vote No MSOP Background
PFE Vote No on MSOP Background

AFSCME's 1.6 million members provide the vital services that make America happen. With members in hundreds of different occupations - from nurses to corrections officers, child care providers to sanitation workers - AFSCME advocates for fairness in the workplace, excellence in public services and prosperity and opportunity for all working families.

###

American Federation of State, County
and Municipal Employees, AFL-CIO
1625 L Street, N.W. Washington, D.C. 20036-5687
Telephone (202) 429-1145
Fax (202) 429-1120

 

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.